Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets Parentheticals

v3.26.1
Consolidated Balance Sheets Parentheticals - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Total assets $ 46,845 [1] $ 47,882
Total liabilities 38,173 34,804
Cash and cash equivalents 1,305 [1] 1,099
Restricted cash and cash equivalents $ 463 [1] $ 485
Preferred Stock, Par Value $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized 5,000,000.0 5,000,000.0
Preferred Stock, Shares Issued 0 0
Common Stock, Par Value Per Share $ 0.003 $ 0.003
Common stock, Shares Authorized 480,000,000.0 480,000,000.0
Common Stock, Shares, Issued 279,600,000 279,200,000
Treasury Stock, Common 69,500,000 66,800,000
Variable Interest Entities [Member]    
Total assets $ 16,649 $ 17,270
Total liabilities 16,968 16,956
Cash and cash equivalents 279 182
Restricted cash and cash equivalents $ 22 $ 22
[1] Amounts presented include balances held by our VIEs, all of which were related to CQP as of March 31, 2026, and substantially all of which were related to CQP as of December 31, 2025. As of March 31, 2026, total assets and liabilities of our VIEs were $16.6 billion and $17.0 billion, respectively, as further detailed in Note 6—Non-Controlling Interests and Variable Interest Entities, including $279 million of cash and cash equivalents and $22 million of restricted cash and cash equivalents.